Has Andrew Levy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $363,633 in general payments to Andrew Levy, MD across 241 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Levy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Levy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Levy, MD

Orthopaedic Surgery · Millburn, NJNPI 1386712032

Payments from drug & device makers

What this record shows

This record is dominated by other: $227,966 of the $363,633 with a category attached, or 62.7%. Smith+Nephew accounts for 86.1% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $267,024 and has fallen 83.1% since, to $45,098 in 2025. Among orthopaedic surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$363,633in general payments, 2019–2025

Across 241 payments — averaging $1508.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$313K
Bioventus LLC$28K
Zimmer Biomet$19K
Stryker$1K
Encore Medical, LP$743
Biorez, Inc.$500
plus $1K from 17 others

$19,700in research payments, 2019–2025

Across 10 payments — averaging $1970.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Aesculap Biologics, LLC$18K
Bioventus LLC$2K

What the payments were for

Consulting fees$65,33518%
Speaking & faculty fees$29,9008%
Travel & lodging$15,6394%
Food & beverage$7,0162%
Education$17,7775%
Other$227,96663%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	141	$313,028
Bioventus LLC	40	$27,684
Zimmer Biomet	17	$19,220
Stryker	10	$1,304
Encore Medical, LP	10	$743
Biorez, Inc.	1	$500
Joint Restoration Foundation, Inc.	1	$289
Anika Therapeutics, Inc.	3	$235
Biotronik NRO, Inc.	1	$126
Amniox Medical, Inc.	1	$100
Medical Device Business Services, Inc.	1	$84
Arthrex	1	$82
Johnson & Johnson	2	$42
Vericel Corporation	2	$35
Abbott	1	$31
Pacira Therapeutics, Inc.	2	$25
Avanos Medical	1	$17
Biodelivery Sciences International, Inc.	1	$17
Kowa Pharmaceuticals America, Inc.	1	$16
Heron Therapeutics, Inc.	1	$16
Ferring Pharmaceuticals Inc.	1	$15
Baudax Bio Inc.	1	$12
Pacira Pharmaceuticals Incorporated	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AccuFill$9,970
Arcos$5,300
Persona$2,507
Other$1,259
Oxford$1,038
Regeneten$854
ICONIX$741
ACUFEX Meniscal Root Repair$582
BioBrace 23mm$500
BioBrace 5mm$500
REGENESORB$470
Healicoil$420
SPEEDLOCK Shoulder$352
DJO Surgical AltiVate Anatomic System$318
INSPACE$300
DJO SURGICAL$291
AGILI-C$286
REGENETEN Shoulder$262
MULTIFIX S$219
LENS Surgical Imaging System$142

How this compares

$363,633 in reported general payments places this provider in the 95th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey →

Medicare billing

Part B allowed, 2024

$7,050

Medicare patients

Services billed

161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	21	$100

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Millburn

Michael KellyHackensack$9.7M
Mark HartzbandParamus$9.4M
Randal BetzLawrenceville$3M
Luke AustinSewell$2.9M
Kenneth MontgomeryMorristown$2.7M
Zachary PostEgg Harbor Township$1.7M
Harlan LevineMontvale$1.5M
Jeffrey AbramsPrinceton$1.5M
Gregg KleinParamus$1.5M
David NazarianMarlton$1.3M

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →